(en) Sveinbjornsdottir, S. (11 juli 2016). The clinical symptoms of Parkinson's disease.. Journal of Neurochemistry139: 318–324. ISSN: 0022-3042. PMID27401947. DOI: 10.1111/jnc.13691.
(en) Barranco Quintana, J.L., Allam, M.F., Del Castillo, A.S., & Navajas, R.F. (februari 2009). Parkinson's disease and tea: a quantitative review.. Journal of the American College of Nutrition28 (1): 1-6. PMID19571153. DOI: 10.1080/07315724.2009.10719754.
(en) Collaborators Global Burden of Disease Study 2013 (22 augustus 2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.. Lancet (London, England)386 (9995): 743–800. PMID26063472. PMC4561509. DOI: 10.1016/s0140-6736(15)60692-4.
(en) Lock EA, Zhang J, Checkoway H. (1 februari 2013). Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.. Toxicology and Applied Pharmacology. 2013 Feb 1;266(3):345–55.266 (3): 345–55. ISSN: 1096-0333. PMID23220449. PMC3621032. DOI: 10.1016/j.taap.2012.11.016. Dit is een open access artikel.
(en) Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., ... & Yahr, M. D. (13 juni 2004). Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson's disease. Movement Disorders19 (9): 1020–1028. DOI: 10.1002/mds.20213.
Rodriguez-Oroz, M.C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E. & Obeso, J.A. (december 2009). Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol8 (12): 1128–139. PMID19909911. DOI: 10.1016/S1474-4422(09)70293-5.
(en) Yao, S.C., Hart, A.D., & Terzella, M.J. (mei 2013). An evidence-based osteopathic approach to Parkinson disease. Osteopathic Family Physician5 (3): 96–101. DOI: 10.1016/j.osfp.2013.01.003.
(en) Russell, J.A., Ciucci, M.R., Connor, N.P., & Schallert, T. (23 juni 2010). Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Research1341: 3–11. PMID20233583. PMC2908992. DOI: 10.1016/j.brainres.2010.03.029.
(en) Caballol, N., Martí, M.J., & Tolosa, E. (september 2007). Cognitive dysfunction and dementia in Parkinson disease. Movement Disorders22 (Suppl 17): S358–66. PMID18175397. DOI: 10.1002/mds.21677.
(en) Parker, K.L., Lamichhane, D., Caetano, M.S., Narayanan, N.S. (oktober 2013). Executive dysfunction in Parkinson's disease and timing deficits. Front. Integr. Neurosci.7. PMID24198770. PMC3813949. DOI: 10.3389/fnint.2013.00075.
(en) Ceravolo, R., Frosini, D., Rossi, C., & Bonuccelli, U. (december 2009). Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat. Disord.15 (Suppl 4): S111–15. PMID20123548. DOI: 10.1016/S1353-8020(09)70847-8.
(en) Barichella, M., Cereda, E., & Pezzoli, G. (oktober 2009). Major nutritional issues in the management of Parkinson's disease. Mov. Disord.24 (13): 1881–92. PMID19691125. DOI: 10.1002/mds.22705.
(en) Sveinbjornsdottir, S. (11 juli 2016). The clinical symptoms of Parkinson's disease.. Journal of Neurochemistry139: 318–324. ISSN: 0022-3042. PMID27401947. DOI: 10.1111/jnc.13691.
(en) Barranco Quintana, J.L., Allam, M.F., Del Castillo, A.S., & Navajas, R.F. (februari 2009). Parkinson's disease and tea: a quantitative review.. Journal of the American College of Nutrition28 (1): 1-6. PMID19571153. DOI: 10.1080/07315724.2009.10719754.
(en) Collaborators Global Burden of Disease Study 2013 (22 augustus 2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.. Lancet (London, England)386 (9995): 743–800. PMID26063472. PMC4561509. DOI: 10.1016/s0140-6736(15)60692-4.
(en) Lock EA, Zhang J, Checkoway H. (1 februari 2013). Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.. Toxicology and Applied Pharmacology. 2013 Feb 1;266(3):345–55.266 (3): 345–55. ISSN: 1096-0333. PMID23220449. PMC3621032. DOI: 10.1016/j.taap.2012.11.016. Dit is een open access artikel.
Rodriguez-Oroz, M.C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E. & Obeso, J.A. (december 2009). Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol8 (12): 1128–139. PMID19909911. DOI: 10.1016/S1474-4422(09)70293-5.
(en) Russell, J.A., Ciucci, M.R., Connor, N.P., & Schallert, T. (23 juni 2010). Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Research1341: 3–11. PMID20233583. PMC2908992. DOI: 10.1016/j.brainres.2010.03.029.
(en) Caballol, N., Martí, M.J., & Tolosa, E. (september 2007). Cognitive dysfunction and dementia in Parkinson disease. Movement Disorders22 (Suppl 17): S358–66. PMID18175397. DOI: 10.1002/mds.21677.
(en) Parker, K.L., Lamichhane, D., Caetano, M.S., Narayanan, N.S. (oktober 2013). Executive dysfunction in Parkinson's disease and timing deficits. Front. Integr. Neurosci.7. PMID24198770. PMC3813949. DOI: 10.3389/fnint.2013.00075.
(en) Ceravolo, R., Frosini, D., Rossi, C., & Bonuccelli, U. (december 2009). Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat. Disord.15 (Suppl 4): S111–15. PMID20123548. DOI: 10.1016/S1353-8020(09)70847-8.
(en) Barichella, M., Cereda, E., & Pezzoli, G. (oktober 2009). Major nutritional issues in the management of Parkinson's disease. Mov. Disord.24 (13): 1881–92. PMID19691125. DOI: 10.1002/mds.22705.
(en) Sveinbjornsdottir, S. (11 juli 2016). The clinical symptoms of Parkinson's disease.. Journal of Neurochemistry139: 318–324. ISSN: 0022-3042. PMID27401947. DOI: 10.1111/jnc.13691.
(en) Lock EA, Zhang J, Checkoway H. (1 februari 2013). Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.. Toxicology and Applied Pharmacology. 2013 Feb 1;266(3):345–55.266 (3): 345–55. ISSN: 1096-0333. PMID23220449. PMC3621032. DOI: 10.1016/j.taap.2012.11.016. Dit is een open access artikel.